Immature lung problems: can our nomenclature be more specific?

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Respiratory Physiology

Background:

• Surfactant therapy has improved outcomes for hyaline membrane disease.
• Pulmonary hypoplasia persists in premature infants despite biochemical recovery.
• Structural lung immaturity limits gas exchange capacity in neonates.

Purpose of the Study:

• To re-evaluate the terminology used for lung problems in premature infants.
• To better reflect the pathophysiology of chronic lung disease in neonates.
• To address the persistent challenges of pulmonary hypoplasia post-surfactant therapy.

Main Methods:

• Review of clinical data and outcomes in premature infants.
• Analysis of the pathophysiology of neonatal lung immaturity.
• Literature review on current terminology and its accuracy.

Main Results:

• Premature infants often exhibit pulmonary hypoplasia, characterized by reduced alveoli count.
• Inadequate gas exchange necessitates prolonged mechanical ventilation.
• Ventilator-associated complications include hypoxia, oxygen toxicity, and barotrauma.

Conclusions:

• Current terminology may not accurately describe the structural lung issues in recovering premature infants.
• Revised terminology is needed to better align with the pathophysiology of neonatal lung immaturity.
• Addressing pulmonary hypoplasia is crucial for improving long-term respiratory outcomes in preterm neonates.